Literature DB >> 28315122

Cardio-oncology: the Nuclear Option.

Jorge A Alvarez1, Raymond R Russell2.   

Abstract

PURPOSE OF REVIEW: Cardio-oncology focuses increased effort to decrease cancer treatment-related cardiotoxicity while continuing to improve outcomes. We sought to synthesize the latest in nuclear cardiology as it pertains to the assessment of left ventricular function in preventative guidelines and comparison to other modalities, novel molecular markers of pre-clinical cardiotoxicity, and its role in cardiac amyloid diagnosis. RECENT
FINDINGS: Planar ERNA (equilibrium radionuclide angiocardiography) provides a reliable and proven means of monitoring and preventing anthracycline cardiotoxicity, and SPECT ERNA using solid-state gamma cameras may provide reproducible assessments of left ventricular function with reduced radiation exposure. While certain chemotherapeutics have vascular side effects, the use of stress perfusion imaging has still not been adequately studied for routine use. Similarly, markers of apoptosis, inflammation, and sympathetic nerve dysfunction are promising, but are still not ready for uniform usage. SPECT tracers can assist in nonbiopsy diagnosis of cardiac amyloid. Nuclear cardiology is a significant contributor to the multimodality approach to cardio-oncology.

Entities:  

Keywords:  Anthracycline; Cardio-oncology; Cardiotoxicity; Nuclear imaging; Trastuzumab

Mesh:

Substances:

Year:  2017        PMID: 28315122     DOI: 10.1007/s11886-017-0844-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  50 in total

1.  Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes.

Authors:  Hiroshi Hirose; Toshihide Kawai; Yukihiro Yamamoto; Matsuo Taniyama; Motowo Tomita; Koichi Matsubara; Yasunori Okazaki; Tatsuya Ishii; Yuko Oguma; Izumi Takei; Takao Saruta
Journal:  Metabolism       Date:  2002-03       Impact factor: 8.694

2.  5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel.

Authors:  Mohamed H Abou El Fadl; Rajesh K Bagai; Timothy P Spiro; Hamad A Daw
Journal:  Gastrointest Cancer Res       Date:  2009-07

3.  Molecular imaging of misfolded protein pathology for early clues to involvement of the heart.

Authors:  Giampaolo Merlini; Jagat Narula; Eloisa Arbustini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-03       Impact factor: 9.236

4.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection.

Authors:  J Narula; E R Acio; N Narula; L E Samuels; B Fyfe; D Wood; J M Fitzpatrick; P N Raghunath; J E Tomaszewski; C Kelly; N Steinmetz; A Green; J F Tait; J Leppo; F G Blankenberg; D Jain; H W Strauss
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

5.  I-123 MIBG and serial radionuclide angiocardiography in doxorubicin-related cardiotoxicity.

Authors:  R A Valdés Olmos; W W ten Bokkel Huinink; J C Greve; C A Hoefnagel
Journal:  Clin Nucl Med       Date:  1992-03       Impact factor: 7.794

6.  Cardiac dysfunction in the trastuzumab clinical trials experience.

Authors:  Andrew Seidman; Clifford Hudis; Mary Kathryn Pierri; Steven Shak; Virginia Paton; Mark Ashby; Maureen Murphy; Stanford J Stewart; Deborah Keefe
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

7.  Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.

Authors:  Paolo Spallarossa; Silvano Garibaldi; Paola Altieri; Patrizia Fabbi; Valeria Manca; Sabina Nasti; Pierfranco Rossettin; Giorgio Ghigliotti; Alberto Ballestrero; Franco Patrone; Antonio Barsotti; Claudio Brunelli
Journal:  J Mol Cell Cardiol       Date:  2004-10       Impact factor: 5.000

8.  Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake.

Authors:  T Nousiainen; E Vanninen; E Jantunen; J Remes; J Kuikka; J Hartikainen
Journal:  Clin Physiol       Date:  2001-01

9.  Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: comparative study with myocardial perfusion, left ventricular function, and histopathological findings.

Authors:  Kimimasa Saito; Kan Takeda; Kyoko Imanaka-Yoshida; Hiroshi Imai; Takao Sekine; Yuko Kamikura
Journal:  Ann Nucl Med       Date:  2003-09       Impact factor: 2.668

10.  Identification of the molecular basis of doxorubicin-induced cardiotoxicity.

Authors:  Sui Zhang; Xiaobing Liu; Tasneem Bawa-Khalfe; Long-Sheng Lu; Yi Lisa Lyu; Leroy F Liu; Edward T H Yeh
Journal:  Nat Med       Date:  2012-10-28       Impact factor: 53.440

View more
  6 in total

1.  Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data.

Authors:  Hubert Tissot; Véronique Roch; Olivier Morel; Nicolas Veran; Mathieu Perrin; Marine Claudin; Antoine Verger; Gilles Karcher; Pierre-Yves Marie; Laetitia Imbert
Journal:  J Nucl Cardiol       Date:  2019-02-27       Impact factor: 5.952

2.  Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018).

Authors:  F J de Haro-Del Moral; I Casans-Tormo; V Pubul-Nuñez; S Aguadé-Bruix
Journal:  Clin Transl Oncol       Date:  2019-05-29       Impact factor: 3.405

Review 3.  Nuclear cardio-oncology: From its foundation to its future.

Authors:  Milan G Kahanda; Christopher A Hanson; Brandy Patterson; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-02-20       Impact factor: 5.952

4.  Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.

Authors:  Fabian Muehlberg; Stephanie Funk; Leonora Zange; Florian von Knobelsdorff-Brenkenhoff; Edyta Blaszczyk; Alexander Schulz; Saeed Ghani; Annete Reichardt; Peter Reichardt; Jeanette Schulz-Menger
Journal:  ESC Heart Fail       Date:  2018-04-19

5.  Relationship Between Quality of Life Indicators and Cardiac Status Indicators in Chemotherapy Patients.

Authors:  Blaž Matija Geršak; Andreja Kukec; Henning Steen; Moritz Montenbruck; Maja Šoštarič; Arne Kristian Schwarz; Sebastian Esch; Sebastian Kelle; Sorin Giusca; Grigorios Korosoglou; Pia Wülfing; Susan Dent; Daniel Lenihan
Journal:  Zdr Varst       Date:  2021-10-20

Review 6.  Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.

Authors:  David Kersting; Stephan Settelmeier; Ilektra-Antonia Mavroeidi; Ken Herrmann; Robert Seifert; Christoph Rischpler
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.